Key metabolites such as linoleic acid, panaxynol, methyl linoleate, palmitoleic acid, and oleic acid have been identified to interact with critical targets in gastric cancer, including EGFR, MAPK1, MAPK3, and IL-6, significantly inhibiting the proliferation of gastric cancer cells (Cui, 2022). The gene discussed is MAPK1; the disease is gastric cancer.